Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia.

× No keyword cloud information.

49 in total

Review 1. Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors: Carrie K Jones; Nellie Byun; Michael Bubser
Journal: Neuropsychopharmacology Date: 2011-09-28 Impact factor: 7.853

Review 2. Glutamate receptor ion channels: structure, regulation, and function.

Authors: Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal: Pharmacol Rev Date: 2010-09 Impact factor: 25.468

Review 3. Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies.

Authors: Emilia H Moscato; Ankit Jain; Xiaoyu Peng; Ethan G Hughes; Josep Dalmau; Rita J Balice-Gordon
Journal: Eur J Neurosci Date: 2010-07-14 Impact factor: 3.386

Review 4. Oxidative stress in schizophrenia: an integrated approach.

Authors: Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal: Neurosci Biobehav Rev Date: 2010-10-23 Impact factor: 8.989

5. Controlled substances and innovation of biomedicine: a preclinical perspective.

Authors: Adam Michael Stewart; Allan V Kalueff
Journal: Nat Rev Neurosci Date: 2013-10-23 Impact factor: 34.870

6. Deletion of the Mitochondrial Matrix Protein CyclophilinD Prevents Parvalbumin Interneuron Dysfunctionand Cognitive Deficits in a Mouse Model of NMDA Hypofunction.

Authors: Aarron Phensy; Kathy L Lindquist; Karen A Lindquist; Dania Bairuty; Esha Gauba; Lan Guo; Jing Tian; Heng Du; Sven Kroener
Journal: J Neurosci Date: 2020-06-30 Impact factor: 6.167

7. Testing the glutamate hypothesis of schizophrenia.

Authors: Joshua A Gordon
Journal: Nat Neurosci Date: 2010-01 Impact factor: 24.884

8. Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex.

Authors: Yan-Chun Li; Dong Xi; Joy Roman; Yue-Qiao Huang; Wen-Jun Gao
Journal: J Neurosci Date: 2009-12-09 Impact factor: 6.167

9. A low dose of the alpha2 agonist clonidine ameliorates the visual attention and spatial working memory deficits produced by phencyclidine administration to rats.

Authors: J David Jentsch; Luigi A Anzivino
Journal: Psychopharmacology (Berl) Date: 2004-03-06 Impact factor: 4.530

10. Periadolescent exposure to the NMDA receptor antagonist MK-801 impairs the functional maturation of local GABAergic circuits in the adult prefrontal cortex.

Authors: Daniel R Thomases; Daryn K Cass; Kuei Y Tseng
Journal: J Neurosci Date: 2013-01-02 Impact factor: 6.167